Mumbai: Cosmo Pharmaceuticals N.V. and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. have announced the signing of distribution and license agreements for Winlevi.
Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi in Europe and South Africa theprint.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theprint.in Daily Mail and Mail on Sunday newspapers.
Cosmo and Glenmark sign Distribution and License Agreements for Winlevi® in Europe and South Africa equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Under the terms of the agreements, Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialise Winlevi in 15 EU countries (Bulgaria, the Czech Republic, Denmark, Finland, France, Hungary, Iceland, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain and Sweden) as well as in South Africa and the UK.
Cosmo Pharmaceuticals N.V. / Key word(s): Contract27-Sep-2023 / 06:00 GMT/BSTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement. Cassiopea, the subsidiary of Cosmo, will be responsible for Centralized Marketing Authorization at European Medic.